Laure-Anne Teuwen unpaid staff

Publications Laure-Anne Teuwen

A phase 1a/1b study of fostroxacitabine Bralpamide (Fostrox) monotherapy in hepatocellular carcinoma and solid tumor liver metastases

Source
Journal of Hepatocellular Carcinoma - ISSN 2253-5969-11 (2024) p. 2033-2047
Author(s)
    Ruth Plummer, Alastair Greystoke, Gregory Naylor, Debashis Sarker, A.N.M. Kaiser Anam, Hans Prenen, Laure-Anne Teuwen, Eric Van Cutsem, Jeroen Dekervel, Beate Haugk, Thomas Ness, Sujata Bhoi, Malene Jensen, Tom Morris, Pia Baumann, Niclas Sjogren, Karin Tunblad, Hans Wallberg, Fredrik Oberg, Thomas R. Jeffry Evans

Intersectionality between country, gender and funding in authorship for phase III trials presented at the ASCO Annual Meeting 2022

Source
JCO global oncology - ISSN 2687-8941-10 (2024) p. 1-9
Author(s)
    Laure-Anne Teuwen, Joanna Young, Saleh Alessy, Berna C. Ozdemir, Diah Martina, Sharif Folorunso, Maria T. Bourlon, Hans Prenen, Eva Segelov

Time to update-requesting inclusive submission categories for oncology research

Source
JCO global oncology - ISSN 2687-8941-10 (2024) p. 1-2
Author(s)

Conflict of interest disclosure in oncology : preliminary insights from the global ONCOTRUST-1 cross-sectional study

Source
JCO global oncology - ISSN 2687-8941-10 (2024) p. 1-9
Author(s)
    Khalid El Bairi, Salma Najem, Arman Reza Chowdhury, Abeid Omar, Omar Abdihamid, Laure-Anne Teuwen, Nada Benhima, Ainhoa Madariaga, Safa Elkefi, Fernando Cristobal Diaz, Sadaqat Hussain, Kristina Jenei, Nazik Hammad, Miriam Mutebi, Fidel Rubagumya, Dario Trapani, Nadia El Kadmiri, Nasser Laouali, Maryam Fourtassi

Novel therapeutic strategies in pancreatic cancer : moving beyond cytotoxic chemotherapy

Source
Expert review of anticancer therapy - ISSN 1473-7140-23:12 (2023) p. 1237-1249
Author(s)